Erythropoietin should be part of congestive heart failure management

Slides:



Advertisements
Similar presentations
Renal involvement in hepatitis C infection: Cryoglobulinemic glomerulonephritis Giuseppe D’Amico Kidney International Volume 54, Issue 2, Pages
Advertisements

Renal Stress Testing in the Assessment of Kidney Disease Lakhmir S. Chawla, Claudio Ronco Kidney International Reports Volume 1, Issue 1, Pages (May.
Pathophysiology of renal fluid retention
Anemia management in chronic kidney disease
Mitchell H. Rosner, W. Kline Bolton  Kidney International 
Erythropoietin should be part of congestive heart failure management
Volume 56, Pages S95-S98 (November 1999)
Anemia treatment in chronic kidney disease accompanied by diabetes mellitus or congestive heart failure  Steven Fishbane, Nobuyuki Miyawaki  Kidney International 
The Case ∣ Acute renal failure and anemia
Progression of renal failure and hypertensive nephrosclerosis
Volume 64, Issue 3, Pages (September 2003)
Burden of chronic kidney disease: North Africa
Smoking and cardiovascular outcomes in dialysis patients: The United States Renal Data System Wave 2 Study1,2  Robert N. Foley, Charles A. Herzog, Allan.
Pathophysiology of renal fluid retention
Volume 62, Issue 2, Pages (August 2002)
Volume 69, Pages S11-S15 (April 2006)
Albuminuria as a predictor of cardiovascular and renal outcomes in people with known atherosclerotic cardiovascular disease  Johannes F.E. Mann, Qi-Long.
Volume 66, Pages S13-S17 (September 2004)
Anemia as a risk factor for chronic kidney disease
Comorbidity and confounding in end-stage renal disease
Volume 66, Issue 3, Pages (September 2004)
The importance of increased dialysis and anemia management for infant survival in pregnant women on hemodialysis  Sai Subhodhini Reddy, Jean L. Holley 
Volume 74, Issue 3, Pages (August 2008)
Volume 70, Issue 11, Pages (December 2006)
Joseph W. Eschbach, John W. Adamson  Kidney International 
D. Coyne  Kidney International  Volume 69, Pages S1-S3 (May 2006)
The epidemiology of chronic kidney disease
Edmund G. Lowrie  Kidney International 
Prevention of renal failure: The Malaysian experience
Study of Heart and Renal Protection (SHARP)
Saulo Klahr, Jeremiah J. Morrissey  Kidney International 
Volume 70, Issue 12, Pages (December 2006)
Amit X. Garg, William F. Clark, R. Brian Haynes, Andrew A. House 
Fructose intake as a risk factor for kidney stone disease
New insights in uremic toxins
Volume 69, Issue 12, Pages (June 2006)
Volume 69, Issue 3, Pages (February 2006)
Tilman B. Drüeke, Ziad A. Massy  Kidney International 
Presentation of the 2003 Jean Hamburger Award to Robert W. Schrier
Microbiology and outcomes of peritonitis in North America
Nephrology in Latin America, with special emphasis on Brazil
Methods for guideline development
AGEs in foods: Do they play a role in uremia?
Volume 87, Issue 1, Pages (January 2015)
Extracorporeal removal of toxins
Simvastatin in nephrotic syndrome
The global challenge of chronic kidney disease
Nephrology Crossword: Glomerulonephritis
Volume 71, Issue 4, Pages (February 2007)
Homocysteine, renal function, and risk of cardiovascular disease
Volume 73, Issue 9, Pages (May 2008)
Volume 82, Issue 9, Pages (November 2012)
Cardio-Kidney-Damage: a unifying concept
Opportunities for a chronic disease outreach program in China
Peritoneal dialysis in Mexico
Taking a public health approach to the prevention of end-stage renal disease: The NKF Singapore Program  Sylvia Paz B. Ramirez, Stephen I-Hong Hsu, William.
Clinical benefits of slowing the progression of renal failure
Organ transplantation goes to the movies
Volume 70, Pages S84-S90 (November 2006)
Volume 55, Pages S3-S16 (June 1999)
Volume 80, Issue 10, Pages (November 2011)
Charles A. Herzog  Kidney International 
Is complement a target for therapy in renal disease?
Volume 70, Issue 10, Pages (November 2006)
In chronic kidney disease staging the use of the chronicity criterion affects prognosis and the rate of progression  B.O. Eriksen, O.C. Ingebretsen  Kidney.
Recombinant hirudin (lepirudin) as anticoagulant in intensive care patients treated with continuous hemodialysis  Karl-Georg Fischer, M.D., Andreas van.
Volume 74, Issue 10, Pages (November 2008)
Morphology of the heart and arteries in renal failure
Asymmetric dimethylarginine: A cardiovascular risk factor in renal disease?  Danilo Fliser, Jan T. Kielstein, Hermann Haller, Stefanie M. Bode-Böger  Kidney.
Epidemiologic data of renal diseases from a single unit in China: Analysis based on 13,519 renal biopsies  Lei-Shi Li, Zhi-Hong Liu  Kidney International 
Presentation transcript:

Erythropoietin should be part of congestive heart failure management Donald S. Silverberg, Dov Wexler, Miriam Blum, Doran Schwartz, Yoram Wollman, Adrian Iaina  Kidney International  Volume 64, Pages S40-S47 (November 2003) DOI: 10.1046/j.1523-1755.64.s87.7.x Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 1 The Cardio Renal Anemia Syndrome. CHF, congestive heart failure; CKI, chronic kidney insufficiency. Kidney International 2003 64, S40-S47DOI: (10.1046/j.1523-1755.64.s87.7.x) Copyright © 2003 International Society of Nephrology Terms and Conditions